Back to announcement
20260602_SDPC_Keterbukaan Informasi terkait Aksi Korporasi_32096045.pdf
Other Text extracted SDPCSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 329/MPI/DIR/V/2026
Nama Perusahaan Millennium Pharmacon International Tbk
Kode Emiten SDPC
Lampiran 1
Perihal Keterbukaan Informasi terkait Aksi Korporasi - Dividen Tunai - 02062026
Dengan ini Perusahaan Menyampaikan Dividen Tunai, Dividen Tunai
Perseroan melaporkan hal-hal berikut :
Dividen Tunai
Perseroan menyampaikan rencana pembagian Dividen Tunai untuk periode tahun buku 2025
sesuai dengan hasil RUPS Tahunan tanggal 25 Mei 2026 dengan rincian Dividen tahun buku 2025 yang akan
dibayar sebagai berikut :
Total Nilai Dividen sudah Ditentukan
Total Nilai Dividen IDR 3.822.000.000
Efek Bersifat Ekuitas Selain Saham yang bisa dikonversi menjadi saham Tidak
Dividen Per Saham (Jika sudah ada kepastian jumlah saham yang akan IDR 3
dibagi)
Dividen per saham sudah ditentukan
Total Nilai Dividen sekurang-kurangnya IDR 3.822.000.000
Total Nilai Dividen setinggi-tingginya IDR 3.822.000.000
Efek Bersifat Ekuitas selain saham yg bisa dikonversi menjadi saham Tidak
Dividen per saham IDR 3
Jadwal pembagian dividen:
Tanggal Efektif
Tanggal Cum Dividen di Pasar Reguler dan Pasar Negosiasi 05 Juni 2026
2 HB sebelum recording date
Tanggal Ex Dividen di Pasar Reguler dan Pasar Negosiasi 08 Juni 2026
1 HB setelah Cum dividen di Pasar Reguler & Negosiasi
Tanggal Cum Dividen di Pasar Tunai 09 Juni 2026
HB yang sama dengan tanggal recording date (DPS)
Tanggal Ex Dividen di Pasar Tunai 10 Juni 2026
1 HB setelah Cum dividen di Pasar Tunai
Tanggal Daftar Pemegang Saham (DPS) yang berhak atas 09 Juni 2026 Waktu 16:00
dividen tunai
Paling cepat 16 HB sejak pengumuman
Tanggal Pembayaran Dividen 26 Juni 2026
Selambat-lambatnya 10 HB setelah recording date.
Data Keuangan per 31 Desember 2025 yang mendasari pembagian Dividen adalah sebagai berikut:
Laba Bersih yang didapat diatribusikan kepada entitas induk IDR 38.466.251.197
Page 2
Saldo Laba Ditahan yang Tidak Dibatasi Penggunaannya IDR 194.802.645.122
Total Ekuitas IDR 315.403.246.932
Demikian untuk diketahui.
Hormat Kami,
Millennium Pharmacon International Tbk
Olga Indria Bolang
Corporate Secretary Manager
Millennium Pharmacon International Tbk
Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
Telepon : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id
Nama Pengirim Olga Indria Bolang
Jabatan Corporate Secretary Manager
Tanggal dan Waktu 02-06-2026 10:43
Lampiran 1. Jadwal_Tata Cara Pembagian Dividen Thn Buku 2025.pdf
Dokumen ini merupakan dokumen resmi Millennium Pharmacon International Tbk yang tidak memerlukan tanda
tangan karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. Millennium Pharmacon International
Tbk bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter Number 329/MPI/DIR/V/2026
Issuer Name Millennium Pharmacon International Tbk
Issuer Code SDPC
Attachment 1
Subject Information Disclosure Concerning Corporate Action - Cash Dividend -
We inform report about Corporate Action Schedule , Cash Dividend
The Company reports the following:
Cash Dividend
The Issuer had declared a plan for the distribution of dividends for the fiscal year 2025 in accordance with the results
of Tahunan General Meeting dated 25 May 2026 for the 2025 financial year dividend which will be paid as follows :
Total value of dividend have been Determined
Total Value of Dividend IDR 3.822.000.000
Other securities in the form of equity that are convertible into shares
Dividend per share (if the receiving number of shares has been IDR 3
determined)
Dividend per share have been determined
Minimum total value of dividend IDR 3.822.000.000
Maximum total value of dividend IDR 3.822.000.000
Other securities in the form of equity that are convertible into shares
Dividend per share IDR 3
Dividend distribution schedule :
Effective Date
Dividend cum date in Regular Market and Negotiation Market 05 June 2026
2 Exchange Days before recording date
Dividend ex date in Regular Market and Negotiation Market 08 June 2026
1 Exchange Days after Dividend Cum in Regular and
Dividend cum date in Cash Market 09 June 2026
Exchange Days same as recording date (DPS)
Dividend ex date in Cash Market 10 June 2026
1 Exchange Days after Dividend Cum in Cash Market
Date on which List of Shareholders (DPS) are entitled to cash 09 June 2026 Time 16:00
dividends
Soonest 16 Exchange Days after Announcement
Dividend payment date 26 June 2026
At the Latest 10 Exchange Days after recording date.
The underlying financial data as of 31 December 2025 for the distribution of dividends are as follows :
Net profit attributable to parent entity IDR 38.466.251.197
Page 4
Unrestricted retained earnings IDR 194.802.645.122
Total equity IDR 315.403.246.932
Thus to be informed accordingly.
Respectfully,
Millennium Pharmacon International Tbk
Olga Indria Bolang
Corporate Secretary Manager
Millennium Pharmacon International Tbk
Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
Phone : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id
Sender Name Olga Indria Bolang
Function Corporate Secretary Manager
Date and Time 02-06-2026 10:43
Attachment 1. Jadwal_Tata Cara Pembagian Dividen Thn Buku 2025.pdf
This is an official document of Millennium Pharmacon International Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. Millennium Pharmacon International Tbk is fully
responsible for the information contained within this document.
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Bolang Corporate
p.2 ×2
unresolved
person
Olga Indria Bolang
· Corporate Secretary Manager
p.2 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.